Achilles Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	12	140	-	-
Enterprise Value	11	141	-	-
Last Close Price	0.58	6.51	-	-
PS Ratio	1.81	21.68	-	-
PB Ratio	2.65	29.94	-	-
P/TBV Ratio	2.65	29.94	-	-
EV/Sales Ratio	1.67	21.82	-	-
Debt / Equity Ratio	0.19	0.19	0.85	-2.04
Debt / EBITDA Ratio	-	-	0.51	1.25
Asset Turnover	0.96	0.96	2.80	-
Quick Ratio	2.02	2.02	1.78	0.80
Current Ratio	2.68	2.68	1.80	0.80
Return on Equity (ROE)	-25.00%	-25.00%	355.31%	-
Return on Assets (ROA)	-7.58%	-7.58%	38.85%	-
Return on Capital (ROIC)	-12.54%	-12.54%	92.87%	-
Return on Capital Employed (ROCE)	-	-	87.30%	2573.30%
Earnings Yield	-6.10%	-0.54%	-	-
FCF Yield	-3.31%	-0.28%	-	-
Buyback Yield / Dilution	-1.54%	-1.54%	-	-

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q